Company Quick10K Filing
Kadant
10-Q 2021-04-03 Filed 2021-05-12
10-K 2021-01-02 Filed 2021-03-02
10-Q 2020-09-26 Filed 2020-11-04
10-Q 2020-06-27 Filed 2020-08-05
10-Q 2020-03-28 Filed 2020-05-06
10-K 2019-12-28 Filed 2020-02-25
10-Q 2019-09-28 Filed 2019-11-06
10-Q 2019-06-29 Filed 2019-08-07
10-Q 2019-03-30 Filed 2019-05-08
10-K 2018-12-29 Filed 2019-02-26
10-Q 2018-09-29 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-30 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-07-01 Filed 2017-08-09
10-Q 2017-04-01 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-15
10-Q 2016-10-01 Filed 2016-11-09
10-Q 2016-07-02 Filed 2016-08-10
10-Q 2016-04-02 Filed 2016-05-11
10-K 2016-01-02 Filed 2016-03-16
10-Q 2015-10-03 Filed 2015-11-12
10-Q 2015-07-04 Filed 2015-08-12
10-Q 2015-04-04 Filed 2015-05-13
10-K 2015-01-03 Filed 2015-03-18
10-Q 2014-09-27 Filed 2014-11-05
10-Q 2014-06-28 Filed 2014-08-06
10-Q 2014-03-29 Filed 2014-05-07
10-K 2013-12-28 Filed 2014-03-12
10-Q 2013-09-28 Filed 2013-11-07
10-Q 2013-06-29 Filed 2013-08-07
10-Q 2013-03-30 Filed 2013-05-08
10-K 2012-12-29 Filed 2013-03-13
10-Q 2012-09-29 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-14
10-Q 2011-10-26 Filed 2011-11-09
10-Q 2011-07-02 Filed 2011-08-11
10-Q 2011-04-02 Filed 2011-05-11
10-K 2011-01-01 Filed 2011-03-17
10-Q 2010-10-02 Filed 2010-11-10
10-Q 2010-07-03 Filed 2010-08-12
10-Q 2010-04-03 Filed 2010-05-12
10-K 2010-01-02 Filed 2010-03-16
8-K 2020-10-27
8-K 2020-07-28
8-K 2020-06-18
8-K 2020-05-12
8-K 2020-04-29
8-K 2020-04-22
8-K 2020-02-12
8-K 2019-10-29
8-K 2019-07-30
8-K 2019-05-17
8-K 2019-04-29
8-K 2019-03-06
8-K 2019-02-13
8-K 2018-12-31
8-K 2018-12-14
8-K 2018-12-09
8-K 2018-12-05
8-K 2018-10-29
8-K 2018-07-30
8-K 2018-07-06
8-K 2018-05-16
8-K 2018-04-30
8-K 2018-04-30
8-K 2018-03-07
8-K 2018-02-15
8-K 2018-02-15

Kadant Financials

KAI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Bioquest Corp (BQST)
30DC (TDCH)
BriaCell Therapeutics Corp. (BCTXW)
DD3 Acquisition Corp. II (DDMXW)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
8i Acquisition 2 Corp. (LAX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-07-022011-10-262011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272015-01-032015-04-042015-07-042015-10-032016-01-022016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash444747434253555864735057384145434756661055463717286917574615846575850
Accounts Receivable54565960576159586361706967685961585764626666667269959092889693104106102
Inventory61595152494442425451636260585561646857596359556063908596969286103110108
PP&E10610540107105107109107111114118118119118119117119118118119126127124128131154165170167168171181181179
Assets369362358362351362359361389399442445424418414407416423415458481484471489515788761772741742726958966936
Accounts Payable27242929262323232626282629282726282724243125242529353537353536444240
Long-Term Debt1212771614394328232631282931726464667166279242241207194176361347317
Liabilities1101141081011231218283105104138140119118112114115161123182201197188195206458430429401385353578567531
Stockholders' Equity227220222233228241249249253263269271270267264257264262267276280288283293309330331344340357373380399405
Income Statement ($MM)2011-07-022011-10-262011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272015-01-032015-04-042015-07-042015-10-032016-01-022016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Revenue8284978483877876829195931079910592989210897112106100103110153149149155166164171177174
Cost of Revenue4548604647494540425153516055584853486153625754545788858387939310110399
Gross Profit38363738363834364040424247444744464446445048464953656566687371717474
R&D112212222222221222122222233332333
SG&A262626262526252729293332353233323129303236343435394344464543494847
Tax31-2352-3223224333444343333516866535
Net Income795577910566658797991078989813111121918111616
Cash Flow ($MM)2011-07-022011-10-262011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272015-01-032015-04-042015-07-042015-10-032016-01-022016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash Operating1215-4813137111310691518-5141612614161622473372817102326
Cash Investing1-3-0-0-0-2-1-12-2-54-2-2-2-13-1-1-1-1-3-55-2-2-209-5-5-3-177-3-2
Cash Financing-9-11-1-7-2-10-16-4213-26-9-04-9-5-136-7-1-10203-7-32-17178-18-30